Reven Pharmaceuticals
Golden
About Reven Pharmaceuticals
Reven Pharmaceuticals is a clinical-stage company providing solutions for the treatment of vascular and metabolic-related conditions. Its services offer products such as critical limb ischemia, peripheral arterial disease, coronary artery disease, and endothelial dysfunction that enable patients to get advanced products for their diseases and recover faster. It was founded in 1999 and headquartered in Golden, Colorado.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $67.3M
- Funding stage: Late Stage Venture
- Last round: Series D (Jan 2019)
- Website: reven.com
- Phone: (941) 320-9271
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/reven-pharmaceuticals-161953 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.